top of page
  • Twitter
  • LinkedIn
Scene from the laboratory with microscope, pipette, test tube, syringe, DNA and


The Toronto Cannabis and Cannabinoid Research Consortium brings together researchers and trainees who are actively engaged in research on cannabis and cannabinoids at the University of Toronto and Toronto Academic Health Sciences Network

TC3 is a tri-campus, multi-institution, interdisciplinary Institutional Strategic Initiative at the University of Toronto

Situated at the heart of Canada’s medical research and innovation ecosystem, TC3 has the unique depth and breadth of expertise and the capacity to address almost every crucial and pressing research question related to cannabis and cannabinoids and to translate research findings into real world solutions for society

TC3 will pioneer transformative cannabis and cannabinoid research and training approaches at the convergence of disciplines

Flowchart Describing TC3's integrated approach
Anchor 1

The TC3 is led by an interdisciplinary team of researchers from

3 University of Toronto campuses, 6 faculties, 11 departments and 3 hospital and research institutes


A major focus of my clinical research is to investigate novel biological systems including the brain endocannabinoid system in mood and anxiety disorders as well as to explore novel treatment approaches through clinical trials with a specific interest in neurobiological and clinical effects of cannabinoids. Our lab’s current research projects include Neuroimaging / PET imaging studies evaluating the endocannabinoid system in the human brain in individuals with social anxiety disorder, healthy controls and participants using THC.

We are also planning a clinical pilot trial of cannabidiol in treatment of social anxiety disorder and we are currently conducting survey on cannabis use, perceptions, motivations, risks and benefits in individuals with mood and anxiety disorders, OCD and PTSD and it is planned to expand this to individuals with concurrent disorders

Photo of Stefan Kloiber

Dr. Stefan Kloiber

Centre for Addiction

and Mental Health


My project aims to assess the effects of cannabinoids in pain, anxiety, memory and disease stages of osteoarthritis in mice.

Cannabis is a potential therapy for osteoarthritis and may provide analgesic, anti-inflammatory, antidepressant and disease-modifying effects. The results of this work will inform drug administration protocols for planned clinical studies of cannabis for osteoarthritis pain, as well as provide unique information on the mechanisms by which cannabinoids relieve pain.


Dr. Helena Fetter Filippini


Lab of Dr. Robert Bonin

University of Toronto


Logo of U of T Temerty Faculty of Medici
Logo of U of T Faculty of Arts & Science
Logo of U of T Faculty of Applied Scienc
Logo of U of T Leslie Dan Faculty of Pha
Logo of U of T Department of Cell and Sy
Logo of U of T Faculty of Kinesiology an
Logo of U of T Scarborough.jpg
Logo of CAMH.png
Logo of U of T Institutional Strategic I
bottom of page